MedPath

Incidence of pruritus after intrathecal administration of Fentanyl.

Not yet recruiting
Conditions
Other disturbances of skin sensation,
Registration Number
CTRI/2019/01/016944
Lead Sponsor
MGM Medical college And Hospital
Brief Summary

Patients to be posted for lower limb orthopaedic surgeries under spinal anaesthesia will be included in the study. After informed consent, spinal anaesthesia will be given in L3-4 intervertebral space in sitting position. Hyperbaric Bupivacaine (10 - 15 mg) and Fentanyl (25 mcg) will be injected intrathecally.

After administration of intrathecal fentanyl, occurence and severity of pruritus will be assessed. Severity of pruritus will be scored from 0-2 (where 0 = no pruritus, 1 = mild to moderate pruritus requiring no treatment, 2 = severe pruritus requiring treatment) at 30 min, 1 hour, 2 hour, 4 hour and 6 hour. Site of pruritus will also be documented.

In case of severe pruritus, Inj. Nalbuphine 2 - 3 mg will be given IV. If no response then Inj. Naloxone 0.1 - 0.2 mg will be given.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
85
Inclusion Criteria

Patients receiving spinal anaesthesia using local anaesthetics & Fentanyl for lower limb orthopaedic surgeries.

Exclusion Criteria

1)Patients having skin disease with pruritus 2)Patients having systemic disease with pruritus 3)Patient receiving antihistaminics or steroids 4)Patients with Opioid dependency 5)Patients with Psychiatric disorders.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of pruritusIntraoperative and postoperative for 6 hours
Secondary Outcome Measures
NameTimeMethod
severity of pruritusat 30 min., 1 hour, 2 hour, 4 hour and 6 hour after administration of intrathecal fentanyl

Trial Locations

Locations (1)

MGM medical college and hospital

🇮🇳

Aurangabad, MAHARASHTRA, India

MGM medical college and hospital
🇮🇳Aurangabad, MAHARASHTRA, India
Dr S J Kulkarni
Principal investigator
9881300645
drsanhitakulkarni@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.